Science Update Forum

No Results Found

Delayed reporting of concussions may lead to prolonged post-concussion symptoms

According to a study published in this month’s Journal of Athletic Training, athletes who wait to report a concussion may experience prolonged recovery times. Researchers determined that athletes who delay post-concussion treatment missed close to one more week of activity than those who received immediate treatment. Athletes who do not receive immediate treatment are at risk for further damage to the brain and will most likely take much longer to recover. Previous research has also supported...Read more

DHA helps improve kidney cancer therapy according to new study

According to a new study published in the journal Molecular Cancer Therapeutics, researchers demonstrate that docosahexaenoic acid (DHA) helps reduce renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib.  Regorafenib is one of a new generation of anti-cancer therapies that attack tyrosine kinases. Unfortunately, kidney cancers mutate to resist these therapies. However, DHA metabolites called...Read more

Study demonstrates nutritional supplements improve efficacy of antidepressants

According to an evidence review published earlier this week in the American Journal of Psychiatry, researchers confirmed that certain nutritional supplements can increase the efficacy of antidepressants for individuals with clinical depression. Researchers at Harvard and the University of Melbourne examined 40 clinical trials along with a systematic review of the evidence for nutrient supplements that are used as adjuncts to help with clinical depression. As a result, fish oil, SAMe,...Read more

New study finds vitamin D improves heart function

According to a new study published Monday in the Journal of the American College of Cardiology, researchers demonstrated that vitamin D improves heart function in patients with chronic heart failure. Heart failure affects more than 23 million people worldwide. This statistic emphasizes the significance of this new study because it presents the first evidence that vitamin D supplementation can improve heart function of people with heart failure. The findings could make a meaningful difference in...Read more

New study shows higher doses of omega 3 fatty acids, specifically EPA, are beneficial for depression

Depression is a major cause of disease burden worldwide, affecting approximately 350 million people. For quite some time now, fish oil supplementation has been a recommended adjunct for helping with major depressive disorder (MDD). According to a new meta-analysis published two weeks ago in Translational Psychiatry, researchers have further confirmed the link between intake of omega-3 fatty acids and the reduction in major depressive disorder. This meta-analysis consisted of 13...Read more

New study reveals individuals with metabolic syndrome may require more vitamin E

New research published just two days ago in the American Journal of Clinical Nutrition demonstrated that approximately one-third of Americans who have metabolic syndrome do not absorb dietary vitamin E as effectively as healthy individuals. Vitamin E is a potent antioxidant that is essential to overall health. It is estimated that 35% of Americans have metabolic syndrome, which is characterized by having at least three of the following traits: excess abdominal fat, elevated blood pressure, low...Read more

Chemical exposure may be linked to rising rates in diabetes and obesity

According to a statement issued three days ago by the Endocrine Society, their summary links endocrine-disrupting chemical exposure to two of our biggest public health risks, diabetes and obesity. This news builds upon the Endocrine Society’s 2009 report, which examined the scientific evidence on endocrine-disrupting chemicals (EDCs) and the health risks associated with them. Since 2009, additional research has demonstrated that exposure to EDCs is associated with an increased risk of diabetes...Read more

Low vitamin D associated with age-related cognitive decline and dementia

In a new study published earlier this month in JAMA Neurology, researchers demonstrated a significant association between vitamin D insufficiency and cognitive decline that is specifically seen in Alzheimer's disease and dementia. The results reinforce the importance of identifying vitamin D insufficiency among the elderly. Here, low vitamin D levels were associated with significantly faster rates of decline in memory and executive function performance. This study included approximately...Read more

Resveratrol helps to stabilize Alzheimer's disease biomarker

A new study published last week in the journal Neurology demonstrated that long-term, high-dose resveratrol stabilized amyloid-beta40 (Abeta40) in patients with mild to moderate Alzheimer's disease. This biomarker declines when the disease progresses. Even though this is a single, small study, it is the largest and longest nationwide human clinical trial of high-dose resveratrol to date. The clinical trial was a randomized, phase II, placebo-controlled, double blind study in patients with mild...Read more

New study finds high prevalence of pre-diabetes and diabetes in the U.S.

According to a new study published in JAMA just three days ago, the increasing prevalence of diabetes may be leveling off. That being said, in 2011 through 2012, the estimated prevalence of diabetes among U.S. adults was 14% and the prevalence of pre-diabetes was 38%, which means about half of the U.S. adult population has either diabetes or pre-diabetes. Diabetes is a major cause of illness and death and is still a significant problem in the U.S. The healthcare costs associated with diabetes...Read more

Vitamin D and its role in macular degeneration

Vitamin D has been extensively researched for its benefits in bone health, cancer, inflammation, and the immune system. A new study published in JAMA Ophthalmology last week found that vitamin D may be a critical player in eye health in the prevention of age-related macular degeneration, specifically among women who are genetically susceptible. This may have to do with its role in inflammation, which is believed to be involved in the development of macular degeneration. Macular...Read more

Are you allergic to the fruits and vegetables you eat? You may actually be reacting to the antibiotic residues in the food.

A recent article published in Annals of Allergy, Asthma and Immunology discusses a case of a 10 year-old girl who had an anaphylactic reaction after eating blueberry pie. She had a history of asthma and seasonal allergies, and known allergies to penicillin and cow's milk, but she was not aware of being allergic to any of the ingredients in the pie. After much testing, it was discovered that the reaction was caused by streptomycin-contaminated blueberry. Streptomycin is a well-known antibiotic,...Read more

Green tea polyphenols protect spinal cord neurons against oxidative stress

Green tea polyphenols are a potential new aid for the recovery and regeneration of neurons after spinal cord injury. Several factors contribute to pathological changes secondary to spinal cord injury, with oxidative stress having a very important role. The formation of reaction oxygen species is the basic response to disease and trauma that contributes significantly to the injury. As a result, oxidative stress and inflammation cause the death of neurons and are the main processes leading to...Read more

Can probiotics help prevent obesity?

In a recent study, researchers at Vanderbilt tested a bacteria that can produce a “therapeutic compound” in the gut. The results showed that it stopped weight gain, insulin resistance and other health complications.  Past research has demonstrated that gut bacteria plays a role in the development of obesity, diabetes, and cardiovascular disease.  According to Sean Davis, PhD, assistant professor of pharmacology at Vanderbilt, “The types of bacteria you have in your gut influence your...Read more

Is niacin safe?

There has been some recent negative news about niacin based on the HPS2-THRIVE study, and now we see it again, this time in the New England Journal of Medicine.  Let’s take a closer look at all of this.  First, in the recent HPS2-THRIVE study, which examined an investigational drug from Merck, the researchers state that niacin does not provide any benefits. The drug they looked at is a combination of extended-release niacin and laropiprant, a drug which partially blocks the flushing...Read more

Examining immune-related disorders and microbial balance

It has become increasingly clear that many diseases are triggered or influenced by changes in bacterial populations in the gut. The general view up until now has been that bacteria stimulate the immune system, which leads to inflammation or autoimmune diseases. In a recent study published in Immunity, researchers have painted a more complex picture. The immune system of the gastrointestinal tract not only prevents the invasion of pathogens, but it is more actively involved in the balance...Read more

The human gut has only a limited ability to convert folic acid to 5-MTHF.

There has been a lot of press on the link between MTHFR (methylenetetrahydrofolate reductase) gene mutations and chronic disease. This has resulted in a great deal of concern with the particular form of folate that doctors are giving to their patients. As Director of Clinical and Product Support here at Designs for Health, I personally speak to approximately five doctors a day about this very topic. According to a recent study in the American Journal of Clinical Nutrition, the human gut appears...Read more

New study demonstrates the gut-brain relationship with irritable bowel syndrome

Posted on Thu, Jul 28, 2016 @ 04:37 PM

IB.jpgNew research published last Friday in the Alimentary Pharmacology & Therapeutics demonstrated that there is a distinct brain-gut pathway (psychological symptoms begin first) as well as a separate gut-brain pathway (gut symptoms begin first) as seen in patients with irritable bowel syndrome (IBS). IBS can be a debilitating condition consisting of cramping, abdominal pain, bloating, gas, diarrhea and constipation. It can affect and one’s work, sleep and relationships. 

IBS is associated with the enteric nervous system, which is considered to be the body’s ‘second brain,’ as it is the nervous system that controls the gastrointestinal tract. The enteric nervous system is made up of a self-contained, complex network of neurons, neurotransmitters, and proteins embedded in the lining of the GI system. It is responsible for all aspects of the digestive process, from the esophagus to the stomach and small and large intestines.

In this new study, higher levels of anxiety and depression were significant predictors of developing IBS within one year. In addition, individuals who did not have elevated levels of anxiety and depression at the start of the study but had documented IBS had significantly higher levels of anxiety and depression after one year.

The researchers determined that in 1/3 of patients, a mood disorder precedes IBS while in the other 2/3 of patients, the situation is reversed, where IBS precedes the mood disorder. These results reveal how some patients with IBS have a gastrointestinal disorder that may not only explain their gut symptoms but also their psychological symptoms. 

It is common knowledge that diet is the most effective way to return balance within the gastrointestinal system. According to a recent clinical trial published in Gastroenterology, researchers at University of Michigan’s Health System demonstrated that a low FODMAP diet significantly helped those with IBS. This study measured the degree of relief from a low FODMAP diet and demonstrated improvement in symptoms as well as an increased quality of life in patients with this condition.

Certain diagnostic tests may also be extremely helpful tools, including stool testing as well as food antibody testing.

Patients may also benefit from a combination of botanicals, enzymes, and probiotics to optimize the gastrointestinal environment. Perilla frutescens is an herb native to Eastern Asia that demonstrates antispasmodic, prokinetic, and anti-inflammatory effects, which help normalize and promote health bowel function, and provide relief from GI symptoms. In addition, there are some specific researched strains of Saccharomyces cerevisiae that have been shown to reduce digestive discomfort and abdominal pain in individuals with IBS. Also, 5-HTP is a dominant neurotransmitter in the enteric nervous system. It plays a significant role in pain perception and sleep patterns, and is important for digestion. 5-HTP also is beneficial in helping to reduce anxiety. 

Saccharomyces boulardii is a great addition to this regimen. S. boulardii has been tested for clinical efficacy in numerous gastrointestinal conditions, including antibiotic-associated diarrhea, Clostridium difficile infection, acute diarrhea, traveler’s diarrhea, Crohn’s disease, ulcerative colitis, and Helicobacter pylori infections, as well as IBS.

By Michael Jurgelewicz, DC, DACBN, DCBCN

 

Related DFH Products-  IB Synergy™FloraMyces™

 

For Related Resource Information, please listen to our Nutrient Roundtable: Gastrointestinal Support, with Michael Jurgelewicz, DC, Arland Hill DC, Camille  Gallinger CN, Rebecca Murray APRN.

For Related Resource Information, please watch our webinar: Designs For Health and Diagnostic Solutions Laboratory Present Advances in  Testing of the GI Microbiota

 

 

Source: N. A. Koloski, M. Jones, N. J. Talley. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Alimentary Pharmacology & Therapeutics, 2016; DOI:10.1111/apt.13738

 

Tags: IBS, GI Health, gut health

Follow DFH

THIS INFORMATION IS PROVIDED FOR THE USE OF PHYSICIANS AND OTHER LICENSED HEALTH CARE PRACTITIONERS ONLY. THIS INFORMATION IS INTENDED FOR PHYSICIANS AND OTHER LICENSED HEALTH CARE PROVIDERS TO USE AS A BASIS FOR DETERMINING WHETHER OR NOT TO RECOMMEND THESE PRODUCTS TO THEIR PATIENTS. THIS MEDICAL AND SCIENTIFIC INFORMATION IS NOT FOR USE BY CONSUMERS. THE DIETARY SUPPLEMENT PRODUCTS OFFERED BY DESIGNS FOR HEALTH ARE NOT INTENDED FOR USE BY CONSUMERS AS A MEANS TO CURE, TREAT, PREVENT, DIAGNOSE, OR MITIGATE ANY DISEASE OR OTHER MEDICAL CONDITION.​